<?xml version="1.0" encoding="ISO-8859-1"?>
<!-- generator="Created by as "Netfluence"" -->
<rss version="2.0">
    <channel>
        <title>Health and Medicine Info</title>
        <description>Latest articles from Health and Medicine Info (http://www.health-n-medicine.info)</description>
        <link>http://www.health-n-medicine.info</link>
        <lastBuildDate>Fri, 09 Jan 2009 04:30:10 +0100</lastBuildDate>
        <generator>Created by as "Netfluence"</generator>
        <ttl>3600</ttl>
        <item>
            <title>Hollis-Eden Pharmaceuticals Announces The Beginning Of Phase I/II Clinical Trials For Apoptone</title>
            <link>http://www.health-n-medicine.info/holliseden-pharmaceuticals-announces-the-a7882.html</link>
            <description><![CDATA[In July, 2008, the pharmaceutical company Hollis-Eden announced the start of initial phase trials of the drug Apoptone, used in the treatment of late-stage prostate cancer patients for whom hormone therapy and at least one round of chemotherapy have proved ineffective.]]></description>
            <pubDate>Mon, 11 Aug 2008 18:06:47 +0100</pubDate>
        </item>
    </channel>
</rss>
